Chen-Fu Lo

Targeting Tumor Associated Phosphatidylserine with New Zinc Dipicolylamine-Based Drug Conjugates.

C. Chen, Yu-Wei Liu, B. Gray, 2017, Bioconjugate chemistry.

Rejuvenating hepatic tumor microenvironment immunity with a phosphatidylserine-targeting small molecule drug conjugate.

T. Yeh, L. Tsou, Kuan-Liang Liu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.

H. Hsieh, Jen‐Shin Song, Yu-Wei Liu, 2015, Journal of medicinal chemistry.

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

C. Chen, Y. Chao, T. Yeh, 2019, Translational oncology.

Targeting the Phosphatidylserine-Immune Checkpoint with a Small-Molecule Maytansinoid Conjugate

C. Chen, T. Yeh, T. Hsu, 2022, Journal of medicinal chemistry.

Synthesis and Evaluation of Small Molecule Drug Conjugates Harnessing Thioester-Linked Maytansinoids

C. Chen, T. Yeh, T. Hsu, 2022, Pharmaceutics.

Linker Optimization and Therapeutic Evaluation of Phosphatidylserine-Targeting Zinc Dipicolylamine-based Drug Conjugates.

C. Chen, Yu-Wei Liu, B. Gray, 2019, Journal of medicinal chemistry.

Marine diterpenoid targets STING palmitoylation in mammalian cells

P. Sung, C. Tung, L. Tsou, 2023, Communications chemistry.

BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy

C. Chen, T. Yeh, Min-Hsien Wang, 2020, Translational oncology.